Cellular Biomedicine Group (CBMG) is a US-China biopharmaceutical firm. According to a CBMG company release reported in the article, Shanghai- and Hong Kong-based private equity firm Sailing Capital Overseas Investment and its affiliates invested $30.6 million in CBMG. The article reports the investment amount as $30.6 million. The report does not specify the instrument (equity, debt, etc.) or the intended use of the funds. No revenue, user metrics, past financing rounds, founding year, or additional financial details were provided in the article. All information here is drawn from the cited company release as reported in the article.

Total raised

$31M

Funding rounds

1

Latest round

Equity

Latest activity

Feb 2018